Live Terminal | Security Analysis of ABT
TERMINAL beta
Version: 0.1
Timestamp: 1708837205.231217
Options
100220.KS
52.83%
1809.TW
51.88%
006220.KS
49.51%
0756.HK
49.35%
B7J.DE
48.43%
0T8B.F
-39.43%
009310.KS
-40.63%
SZGPF
-42.69%
GOLL4.SA
-52.40%
HGEN.L
-53.60%
AAPL $182.88 -0.81%
AMD $176.41 -3.00%
AMZN $174.58 0.00%
BRK-B $417.87 0.65%
GOOG $145.44 0.08%
IBM $185.76 0.84%
INTC $43.28 0.71%
JNJ $161.87 0.89%
JPM $184.12 0.57%
META $488.06 0.40%
MSFT $410.31 -0.33%
O $53.27 0.85%
TSLA $195.04 -1.20%
WMT $176.24 0.47%
QQQ $436.78 -0.2945%
TLT $93.87 1.3387%
VUSA.DE $89.31 0.4025%
VUAA.DE $88.65 0.3918%
FJPR.L $5.64 1.5565%
VWRP.L $97.83 0.1638%
VWRL.L $98.54 0.1626%
EMGU.L $3.60 -0.1111%
RDVY $52.42 0.3446%
FLOT $50.98 0.0000%
SCHZ $45.74 0.4171%
IBB $138.19 0.7436%
C020.DE $21.34 0.0000%
DFAX $24.72 0.0810%
LYP6.DE $226.20 0.4440%
MEUD.PA $226.19 0.4173%
IDWR.L $71.10 0.4521%
IQQW.DE $65.72 0.3972%
EXS1.DE $145.70 0.2477%
XESC.L $6865.00 0.1240%
DFAU $35.25 0.0852%
ACWV $104.02 0.2602%
VHYD.L $63.92 0.2746%
VGWD.DE $59.24 0.5602%
FXKZ.ME $303.00 0.0000%

Latest articles

No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.

Sentiment statistics ?
ABT
μ 0.9960
0.996
0.996

Financial Histories

Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.

Overview
ABT
Latest Performance
ABT$119.45
$0.44 • 0.37%
ABT
Price 119.45
Change Pct 0.37
Change Abs 0.44
Market Cap 207.3 billion
Eps 3.26
Pe Ratio 36.64
Outstanding Shares 1.7 billion
Volume 1.6 million
Avg Volume 5.4 million
Industry Medical Devices
Sector Name Health Care
Country Short Name US
Announcement Earnings 2024-04-17 12:30:00+00:00
All metrics in USD or %.
Risk Profiles

Please sign up and become a member to view all risk profiles.

Competitors/Peer Groups
ABT
Same Country:
Same Decade:
Intraday: +2.07%
Focus

The 'Focus' Area is meant to be an One-Pager about all Important Insights, Risks and Opportunities to solely analyze a single corporate.

Company descriptions
ABT

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.